Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1990 | 12-1989 | 12-1988 | 12-1987 | 12-1986 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,365 | 1,378 | 1,211 | 1,537 | 4,368 |
| Marketable Securities | 0 | 0 | 312 | 464 | 2,277 |
| Receivables | 42 | 0 | 0 | 0 | 250 |
| Other current assets | 29 | 6 | 36 | 126 | 32 |
| TOTAL | $1,436 | $1,384 | $1,560 | $2,127 | $6,926 |
| Non-Current Assets | |||||
| PPE Net | 35 | 67 | 102 | 154 | 185 |
| Other Non-Current Assets | 4 | 309 | 12 | 217 | 2 |
| TOTAL | $40 | $375 | $114 | $371 | $187 |
| Total Assets | $1,475 | $1,759 | $1,674 | $2,497 | $7,113 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 262 | 303 | 1,254 | 228 | 230 |
| Accrued Expenses | 236 | 62 | 109 | 215 | 166 |
| Other current liabilities | 7 | 105 | 5 | 3 | 49 |
| TOTAL | $505 | $469 | $1,368 | $446 | $395 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 226 | 20 | 26 | 6 | 0 |
| TOTAL | $226 | $393 | $457 | $6 | $55 |
| Total Liabilities | $731 | $861 | $1,825 | $452 | $450 |
| Shareholders' Equity | |||||
| Common Shares | 160 | 137 | 116 | 101 | 98 |
| Retained earnings | -38,415 | -35,992 | -29,437 | -21,142 | -15,042 |
| Other shareholders' equity | -31 | -26 | -107 | -799 | 0 |
| TOTAL | $744 | $898 | $-151 | $2,045 | $6,663 |
| Total Liabilities And Equity | $1,475 | $1,759 | $1,674 | $2,497 | $7,113 |